Weibo Jiang

446 total citations
28 papers, 267 citations indexed

About

Weibo Jiang is a scholar working on Biomedical Engineering, Surgery and Molecular Biology. According to data from OpenAlex, Weibo Jiang has authored 28 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Biomedical Engineering, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Weibo Jiang's work include Bone Tissue Engineering Materials (7 papers), Orthopaedic implants and arthroplasty (4 papers) and CAR-T cell therapy research (3 papers). Weibo Jiang is often cited by papers focused on Bone Tissue Engineering Materials (7 papers), Orthopaedic implants and arthroplasty (4 papers) and CAR-T cell therapy research (3 papers). Weibo Jiang collaborates with scholars based in China, United States and Tanzania. Weibo Jiang's co-authors include Jincheng Wang, Shui Liu, Mengying Cui, Yang Sun, Yang Sun, Robert L. Sah, Tong Yu, Yang Wang, Yu Tao and Zuobin Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Oncogene.

In The Last Decade

Weibo Jiang

24 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weibo Jiang China 11 91 73 64 51 35 28 267
Kechao Zhu China 9 117 1.3× 79 1.1× 36 0.6× 70 1.4× 23 0.7× 19 286
Natsumi Takamaru Japan 9 85 0.9× 90 1.2× 53 0.8× 59 1.2× 40 1.1× 30 305
Silvia Dolder Switzerland 12 121 1.3× 92 1.3× 67 1.0× 37 0.7× 21 0.6× 22 321
Jia Zhou China 10 100 1.1× 73 1.0× 27 0.4× 74 1.5× 34 1.0× 23 304
Zhenhai Cai China 8 94 1.0× 61 0.8× 52 0.8× 22 0.4× 38 1.1× 14 267
Yanlin Wu China 11 144 1.6× 60 0.8× 40 0.6× 27 0.5× 75 2.1× 28 340
Haiying Dai China 8 95 1.0× 63 0.9× 31 0.5× 45 0.9× 40 1.1× 26 247
Qianmin Gao China 8 124 1.4× 99 1.4× 39 0.6× 26 0.5× 33 0.9× 15 288
Jianhao Huang China 11 99 1.1× 80 1.1× 37 0.6× 28 0.5× 52 1.5× 22 269
Neda Dadgar United States 13 97 1.1× 125 1.7× 97 1.5× 104 2.0× 25 0.7× 37 385

Countries citing papers authored by Weibo Jiang

Since Specialization
Citations

This map shows the geographic impact of Weibo Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weibo Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weibo Jiang more than expected).

Fields of papers citing papers by Weibo Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weibo Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weibo Jiang. The network helps show where Weibo Jiang may publish in the future.

Co-authorship network of co-authors of Weibo Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Weibo Jiang. A scholar is included among the top collaborators of Weibo Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weibo Jiang. Weibo Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qian, Kai, Fulong Zhang, Shuangyu Liu, et al.. (2025). Biomimetic Design and Performance of TPMS Radial Continuous Gradient Porous Bone Scaffolds. Metals and Materials International. 31(11). 3216–3242.
2.
Wang, Lixuan, et al.. (2025). Combination strategies of gut microbiota in cancer therapy through metabolic reprogramming and immune remodeling. Cell Communication and Signaling. 23(1). 270–270. 7 indexed citations
3.
Li, Mufeng, et al.. (2025). Anti-osteosarcoma activity of Corynoline via Src/JNK signaling-mediated cell cycle arrest and mitochondrial apoptosis. International Immunopharmacology. 148. 114126–114126.
4.
Liu, Shiyu, et al.. (2025). Adoptive cell therapy for cancer: combination strategies and biomarkers. Frontiers in Immunology. 16. 1603792–1603792. 1 indexed citations
5.
Wang, Yang, Zhonghan Wang, Weibo Jiang, et al.. (2024). Advanced topology of triply periodic minimal surface structure for osteogenic improvement within orthopedic metallic screw. Materials Today Bio. 27. 101118–101118. 5 indexed citations
6.
Yu, Tong, et al.. (2024). Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review). International Journal of Oncology. 64(4). 8 indexed citations
7.
Jiang, Weibo, et al.. (2024). Osteochondral tissue engineering in translational practice: histological assessments and scoring systems. Frontiers in Bioengineering and Biotechnology. 12. 1434323–1434323.
8.
Cui, Mengying, et al.. (2024). Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance. Cell Communication and Signaling. 22(1). 338–338. 41 indexed citations
9.
Jiao, Jianhang, Lili Yang, Yang Wang, et al.. (2024). Advanced tumor organoid bioprinting strategy for oncology research. Materials Today Bio. 28. 101198–101198. 7 indexed citations
10.
Wang, Yang, Weibo Jiang, Tong Yu, et al.. (2023). Application of advanced biomaterials in photothermal therapy for malignant bone tumors. Biomaterials Research. 27(1). 116–116. 23 indexed citations
11.
Pu, Yijing, et al.. (2023). Potential beneficial effects of functional components of edible plants on COVID-19: Based on their anti-inflammatory and inhibitory effect on SARS-CoV-2. SHILAP Revista de lepidopterología. 2(1). 44–59. 18 indexed citations
12.
Li, Huan, et al.. (2023). Connecting the mechanisms of tumor sex differences with cancer therapy. Molecular and Cellular Biochemistry. 479(2). 213–231. 11 indexed citations
13.
Jiang, Weibo, et al.. (2023). Nanoscale Morphologies on the Surface of 3D-Printed Titanium Implants for Improved Osseointegration: A Systematic Review of the Literature. International Journal of Nanomedicine. Volume 18. 4171–4191. 19 indexed citations
15.
Wang, Haosheng, Kai Wang, Bin Lv, et al.. (2021). Establishment and assessment of a nomogram for predicting blood transfusion risk in posterior lumbar spinal fusion. Journal of Orthopaedic Surgery and Research. 16(1). 39–39. 11 indexed citations
16.
Zhang, Yiqun, et al.. (2020). <p>Impacts of a Nano-Laponite Ceramic on Surface Performance, Apatite Mineralization, Cell Response, and Osseointegration of a Polyimide-Based Biocomposite</p>. International Journal of Nanomedicine. Volume 15. 9389–9405. 10 indexed citations
17.
Tian, Lantian, Ke Yao, Kun Liu, et al.. (2020). PLK1/NF-κB feedforward circuit antagonizes the mono-ADP-ribosyltransferase activity of PARP10 and facilitates HCC progression. Oncogene. 39(15). 3145–3162. 24 indexed citations
18.
Sun, Yang, Weibo Jiang, Esther Cory, et al.. (2017). Pulsed lavage cleansing of osteochondral grafts depends on lavage duration, flow intensity, and graft storage condition. PLoS ONE. 12(5). e0176934–e0176934. 17 indexed citations
19.
Jiang, Weibo, Shu Wang, Yang Sun, et al.. (2017). Overexpression of microRNA-448 inhibits osteosarcoma cell proliferation and invasion through targeting of astrocyte elevated gene-1. Molecular Medicine Reports. 16(4). 5713–5721. 12 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026